Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.
Talbot
M
M
Thrombosis Research, Research Centre, Ciba-Geigy Pharmaceuticals, Horsham, West Sussex, UK.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D024764:Hirudin Therapy; D006629:Hirudins / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013917:Thrombin / Q000037:antagonists & inhibitors; D013927:Thrombosis / Q000188:drug therapy* / Q000517:prevention & control
D006629:Hirudins; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D013917:Thrombin